/

/

/

Corporate reports

Corporate reports

Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

Annual meeting materials

2024
2023
2022
2021
2020
2019
2018
2017

2023 Annual Report

2024 Proxy Statement

2022 Annual Report

2023 Proxy Statement

2021 Annual Report

2022 Proxy Statement

2020 Annual Report

2021 Proxy Statement

2019 Annual Report

2020 Proxy Statement

Board Report on Oversight of Risk Related to Opioids

2018 Annual Report

2019 Proxy Statement

2017 Annual Report

2018 Proxy Statement

2016 Annual Report

2017 Proxy Statement

More from Johnson & Johnson

Innovation

August 30, 2024

What are cataracts?

If you can’t read a screen without jacking up the brightness level or if night driving leaves you seeing fuzzy halos around traffic lights, you may among the 20 million U.S. adults who develops a cataract—the most common cause of vision loss worldwide. Luckily a simple surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.

Personal stories

August 23, 2024

Meet two brothers who are revolutionizing the way scientists develop treatments for cancer

Justin and Colin Farlow share how their next-generation cell and gene therapies are helping Johnson & Johnson in its quest to get in front of cancer.

Health & wellness

July 18, 2024

By the numbers: Understanding dry eye disease

For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.